253 related articles for article (PubMed ID: 19544420)
41. Insulin-producing cells from human pancreatic islet-derived progenitor cells following transplantation in mice.
Zhang Y; Ren Z; Zou C; Wang S; Luo B; Li F; Liu S; Zhang YA
Cell Biol Int; 2011 May; 35(5):483-90. PubMed ID: 21080910
[TBL] [Abstract][Full Text] [Related]
42. Generation of insulin-secreting cells from mouse gallbladder stem cells by small molecules in vitro.
Chen F; Li T; Sun Y; Liu Q; Yang T; Chen J; Zhu H; Shi Y; Hu YP; Wang MJ
Stem Cell Res Ther; 2019 Sep; 10(1):289. PubMed ID: 31547878
[TBL] [Abstract][Full Text] [Related]
43. [Study on differentiation of mesenchymal stem cells derived from human umbilical cord blood into insulin secreting cells].
Chi ZH; Lu Y; Zhang Y
Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):679-83. PubMed ID: 19176063
[TBL] [Abstract][Full Text] [Related]
44. Islet-like organoids derived from human pluripotent stem cells efficiently function in the glucose responsiveness in vitro and in vivo.
Kim Y; Kim H; Ko UH; Oh Y; Lim A; Sohn JW; Shin JH; Kim H; Han YM
Sci Rep; 2016 Oct; 6():35145. PubMed ID: 27731367
[TBL] [Abstract][Full Text] [Related]
45. Evaluating KIND1 human embryonic stem cell-derived pancreatic progenitors to ameliorate streptozotocin-induced diabetes in mice.
Pursani V; Kapoor S; Metkari SM; Nair P; Bhartiya D
Indian J Med Res; 2017 Aug; 146(2):244-254. PubMed ID: 29265026
[TBL] [Abstract][Full Text] [Related]
46. Human urine-derived stem cells play a novel role in the treatment of STZ-induced diabetic mice.
Zhao T; Luo D; Sun Y; Niu X; Wang Y; Wang C; Jia W
J Mol Histol; 2018 Aug; 49(4):419-428. PubMed ID: 29675567
[TBL] [Abstract][Full Text] [Related]
47. Stem-cell success aids diabetes fight.
Ledford H
Nature; 2014 Oct; 514(7522):281. PubMed ID: 25318498
[No Abstract] [Full Text] [Related]
48. Stem cell therapy emerging as the key player in treating type 1 diabetes mellitus.
Vanikar AV; Trivedi HL; Thakkar UG
Cytotherapy; 2016 Sep; 18(9):1077-86. PubMed ID: 27424148
[TBL] [Abstract][Full Text] [Related]
49. Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice.
Vegas AJ; Veiseh O; Gürtler M; Millman JR; Pagliuca FW; Bader AR; Doloff JC; Li J; Chen M; Olejnik K; Tam HH; Jhunjhunwala S; Langan E; Aresta-Dasilva S; Gandham S; McGarrigle JJ; Bochenek MA; Hollister-Lock J; Oberholzer J; Greiner DL; Weir GC; Melton DA; Langer R; Anderson DG
Nat Med; 2016 Mar; 22(3):306-11. PubMed ID: 26808346
[TBL] [Abstract][Full Text] [Related]
50. Establishment of human pluripotent stem cell-derived pancreatic β-like cells in the mouse pancreas.
Ma H; Wert KJ; Shvartsman D; Melton DA; Jaenisch R
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3924-3929. PubMed ID: 29599125
[TBL] [Abstract][Full Text] [Related]
51. Transplantation of bone marrow derived cells promotes pancreatic islet repair in diabetic mice.
Gao X; Song L; Shen K; Wang H; Niu W; Qin X
Biochem Biophys Res Commun; 2008 Jun; 371(1):132-7. PubMed ID: 18420028
[TBL] [Abstract][Full Text] [Related]
52. Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Insulin-Producing Cells: Evidence for Further Maturation In Vivo.
Gabr MM; Zakaria MM; Refaie AF; Khater SM; Ashamallah SA; Ismail AM; El-Halawani SM; Ghoneim MA
Biomed Res Int; 2015; 2015():575837. PubMed ID: 26064925
[TBL] [Abstract][Full Text] [Related]
53. Adult muscle-derived stem cells engraft and differentiate into insulin-expressing cells in pancreatic islets of diabetic mice.
Mitutsova V; Yeo WWY; Davaze R; Franckhauser C; Hani EH; Abdullah S; Mollard P; Schaeffer M; Fernandez A; Lamb NJC
Stem Cell Res Ther; 2017 Apr; 8(1):86. PubMed ID: 28420418
[TBL] [Abstract][Full Text] [Related]
54. Co-transplantation of mesenchymal stromal cells and cord blood cells in treatment of diabetes.
Xiao N; Zhao X; Luo P; Guo J; Zhao Q; Lu G; Cheng L
Cytotherapy; 2013 Nov; 15(11):1374-84. PubMed ID: 24094489
[TBL] [Abstract][Full Text] [Related]
55. Generation of insulin-secreting cells from pancreatic acinar cells of animal models of type 1 diabetes.
Okuno M; Minami K; Okumachi A; Miyawaki K; Yokoi N; Toyokuni S; Seino S
Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E158-65. PubMed ID: 16926384
[TBL] [Abstract][Full Text] [Related]
56. Induction of differentiation of embryonic stem cells into insulin-secreting cells by fetal soluble factors.
Vaca P; Martín F; Vegara-Meseguer JM; Rovira JM; Berná G; Soria B
Stem Cells; 2006 Feb; 24(2):258-65. PubMed ID: 16109755
[TBL] [Abstract][Full Text] [Related]
57. Derivation of insulin producing cells from human endometrial stromal stem cells and use in the treatment of murine diabetes.
Santamaria X; Massasa EE; Feng Y; Wolff E; Taylor HS
Mol Ther; 2011 Nov; 19(11):2065-71. PubMed ID: 21878900
[TBL] [Abstract][Full Text] [Related]
58. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
Bose B; Katikireddy KR; Shenoy PS
Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
[TBL] [Abstract][Full Text] [Related]
59. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
Domouky AM; Hegab AS; Al-Shahat A; Raafat N
Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
[TBL] [Abstract][Full Text] [Related]
60. Enhanced differentiation of human adipose tissue-derived stromal cells into insulin-producing cells with glucagon-like peptide-1.
Wei AH; Wang WJ; Mu XP; Li HM; Yan WQ
Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):28-34. PubMed ID: 21915820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
